Results 91 to 100 of about 10,090 (144)

Effectiveness of first-line lamivudine/dolutegravir antiretroviral therapy in persons with HIV: real-life data from the ICONA Foundation cohort. [PDF]

J Antimicrob Chemother
Vergori A, Cozzi-Lepri A, Lo Caputo S, Tavelli A, Mazzotta V, Schiaroli E, Orofino G, Mussini C, Nozza S, Cingolani A, Antinori A, d'Arminio Monforte A, Icona Foundation Study Group .   +12 more
europepmc   +1 more source

Drug Interactions Are Crucial in the Care of Patients on Opioid Substitutional Therapy-A Case Report. [PDF]

Reports (MDPI)
Devarapalli SK, Furman-Dłubała A, Bednarska A, Kowalska JD.   +3 more
europepmc   +1 more source

Initiation of dolutegravir vs. efavirenz on 12- and 24-month retention and viral suppression: a target trial emulation. [PDF]

Infect Dis (Lond)
Zheng A, Brennan AT, Greener R, Kileel EM, Bor J, Venter WDF, Murray EJ, Pisa PT, Goeieman B, Fox MP, Maskew M.   +10 more
europepmc   +1 more source

Comparative Analysis of Effectiveness of Dolutegravir-Based Regimen (TLD) vs. Efavirenz-Based Regimen (TLE) to Prevent Mother-to-Child Transmission of HIV. [PDF]

Cureus
Kashyap M, Verma A, Pathak D, Gautam S, Gupta M.   +4 more
europepmc   +1 more source

Real-World Outcomes of Antiretroviral Therapy in People Living With HIV in Saudi Arabia: A Three-Year Observational Cohort Study From a Tertiary Care Center. [PDF]

Cureus
Alsaeed A.
europepmc   +1 more source

Low Levels of Clinically Significant Drug Resistance Mutations to Dolutegravir Among Children Living with HIV Failing on First-Line Antiretroviral Therapy in Uganda. [PDF]

J Acquir Immune Defic Syndr
Magongo EN, Hast M, Nabitaka V, Nakanwagi M, Twinomujjuni E, Dowling S, Senyama G, Nzano B, Alwano M, Nakaweesi J, Nazziwa E, Namayanja G, Nkolo E, Ayitewala A, Hackett S.   +14 more
europepmc   +1 more source

Effectiveness of simplified ART regimens in older adults living with HIV: real-world evidence from a Brazilian cohort. [PDF]

Braz J Med Biol Res
Stanicki PV, Tasca KI, Zimmerman WR, Barbosa AN.   +3 more
europepmc   +1 more source

Hypertension and blood pressure changes with dolutegravir or comparator antiretroviral therapy in randomized trials through 96 weeks. [PDF]

J Antimicrob Chemother
Patel P, Milinkovic A, Grove R, Govan L, McKenna M, Wynne B, Henegar C, Martinez E, Dimondi P, Chow K, Payvandi N, Jones B.   +11 more
europepmc   +1 more source